Cor Vasa 2020, 62(1):89-93 | DOI: 10.33678/cor.2019.013

(Paraganglioma-induced takotsubo cardiomyopathy)

Petra Kadlečková, Tomáš Roubíček, Rostislav Polášek
Kardiocentrum Krajské nemocnice Liberec, a.s., Liberec

Takotsubo cardiomyopathy (also known as stress cardiomyopathy or apical balloon syndrome) is an acquired myocardial disease characterized by symptoms similar to acute coronary syndrome. Pathophysiological mechanism of this disorder is still not well understood. Generally accepted mechanism is probably catecholamine-induced myocardial stunning provoked by stress, excessive physical exertion or rarely endocrine active tumors. We present a case report of a patient who was admitted to our clinic for suspected acute coronary syndrome. Subsequent examinations showed that it was a stress cardiomyopathy caused by extraadrenally localized tumor - paraganglioma. By tumor extirpation all clinical symptoms and laboratory results were corrected without need of antihypertensive and antidiabetic therapy.

Keywords: Paraganglioma, Paroxysmal hypertension, Takotsubo cardiomyopathy

Received: March 28, 2019; Accepted: April 1, 2019; Published: February 28, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kadlečková P, Roubíček T, Polášek R. (Paraganglioma-induced takotsubo cardiomyopathy). Cor Vasa. 2020;62(1):89-93. doi: 10.33678/cor.2019.013.
Download citation

References

  1. Sato H, Tateishi H, Uchida T. Takotsubo-type cardiomyopathy due to multivessel spasm, In: Kodama KK, Haze K, Hon M, eds. Clinical Aspect of Myocardial Injury: From Ischemia to Heart Failure ( in Japanese). Tokyo: Kagakuhyouronsya Co, 1990:56-64.
  2. Prasad A, Dangas G, Srinivasan M, et al. Incidence and angiographic characteristics of patients with apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS-AMI trial: an analysis from a multicenter, international study of ST-elevation. myocardial infarction. Catheter Cardiovasc Interv 2014;83:343-348. Go to original source... Go to PubMed...
  3. Akashi YJ, Nef HM, Lyon AR. Epidemiology and pathophysiology of Takotsubo syndrome. Nat Rev Cardiol 2015:12:387-397. Go to original source... Go to PubMed...
  4. Minhas AS, Hughey AB, Kolias TJ. Nationwide Trends in Reported Incidence of Takotsubo Cardiomyopathy from 2006 to 2012. Am J Cardiol 2015;116:1128-1131. Go to original source... Go to PubMed...
  5. Templin C, Ghadri JR, Diekmann J, et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med 2015;373:929-938. Go to original source... Go to PubMed...
  6. Ferreira VM, Marcelino M, Piechnik SK, et al. Pheochromocytoma is Characterized by Catecholamine- -Mediated myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction. J Am Coll Cardiol 2016;67:2364-2374. Go to original source... Go to PubMed...
  7. Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539-548. Go to original source... Go to PubMed...
  8. Schneider B, Athanasiadis A, Stöllberger C, et al. Gender differences in the manifestation of tako-tsubo cardiomyopathy. Int J Cardiol 2013;166:584-588. Go to original source... Go to PubMed...
  9. Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart J 2018;39:2032-2046. Go to original source... Go to PubMed...
  10. Pison L, De Vusser P, Mullens W. Apical ballooning in relatives. Heart 2004;90:e67. Go to original source... Go to PubMed...
  11. Beard CM, Sheps SG, Kurlanf LT, et al. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1983;58:802-804.
  12. Welander J, Söderkvist P, Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 2011;18:253-276. Go to original source... Go to PubMed...
  13. Erickson D, Kudva YC, Ebersold MJ, et al. Benign Paragangliomas: Clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 2001;86:5210-5216. Go to original source... Go to PubMed...
  14. Zalewska AM, Gajewska HB, Kazberuk AT, et al. Takotsubo cardiomyopathy: serious early complications and two-year mortality - a 101 case study. Neth Heart J 2016;24:511-519. Go to original source... Go to PubMed...
  15. Gagnon N, Mansour S, Bitton Y, et al. Takotsubo- -like cardiomyopathy in a large cohort of patients with pheochromocytoma and paraganglioma. Endocr Pract 2017;23:1178-1192. Go to original source... Go to PubMed...
  16. Scantlebury DC, Prasad A. Diagnosis of Takotsubo cardiomyopathy. Circ J 2014;78:2129-2139. Go to original source... Go to PubMed...
  17. Frangiegh AH, Obeid S, Ghadri JR. ECG Criteria to Differentiate Between Takotsubo (Stress) Cardiomyopathy and Myocardial Infarction. J Am Heart Assoc 2016;5:e003418. Go to original source... Go to PubMed...
  18. Al-Harthy M, Al-Harthy S, Al-Otieschan A, et al. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas. Endocr Pract 2009;15:194-202. Go to original source... Go to PubMed...
  19. Ghadri JR, Cammann VL, Napp LC, et al. International Takotsubo Registry, Differences in the Clinical Profile and Outcomes of Typical and Atypical Takotsubo Syndrome: Data From the International Takotsubo Registry. JAMA Cardiol 2016;1:335-340. Go to original source... Go to PubMed...
  20. Yu R, Wei M. False positive test results for pheochromocytoma from 2000 to 2008. Exp Clin Endocrinol Diabetes 2010;118:577-585. Go to original source... Go to PubMed...
  21. Wachtel H, Cerullo I, Bartlett EK, et al. Clinicopathologic characteristics of incidentally identified pheochromocytoma, Ann Surg Oncol 2014;22:132-138. Go to original source... Go to PubMed...
  22. Nockel P, El Lakis M, Gaitanidis A, et al. Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery. Ann Surg 2019;269:741-747. Go to original source... Go to PubMed...
  23. Kohlenberg J, Welch B, Hamidi O, et al. Efficacy and Safety of Ablative Therapy in the Treatment of Patients with Metastatic Pheochromocytoma and Paraganglioma Cancers 2019;11:E195. Go to original source... Go to PubMed...
  24. McBride JF, Atwel TD, Charboneau WJ, et al. Minimally invasive treatment of metastatic pheochromocytoma and paraganglioma: efficacy and safety of radiofrequency ablation and cryoablation therapy. J Vasc Interv Radiol 2011;22:1263-1270. Go to original source... Go to PubMed...
  25. Kawai S, Kitabatake A, Tomoike H, et al. Guidelines for diagnosis of takotsubo (ampulla) cardiomyopathy. Circulation J 2007;71:990-992. Go to original source... Go to PubMed...
  26. Bybee KA, Prasad A. Stress-Related Cardiomyopathy Syndromes. Circulation 2008;118:397-409. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.